The epidemiology of irritable bowel syndrome.
The epidemiology of irritable bowel syndrome.
复制标题
DOI：
10.2147/clep.s40245
复制
发表时间：
2014
影响因子：
3.9
通讯作者：
Card T
中科院分区：
文献类型：
--
作者：
Canavan C;West J;Card T
肠易激综合征（IBS）是一种使用临床标准诊断的肠道功能性疾病。本文讨论了IBS诊断过程的性质以及这如何影响流行病学测量。根据所采用的诊断标准，IBS影响全球约11%的人口。大约30%经历IBS症状的人会咨询医生他们的IBS症状。这些人没有显着不同的腹部症状，那些谁不咨询，但他们确实有更大的焦虑水平和生活质量较低。在国际上，IBS的患病率以女性为主。在50岁以上的人群中诊断出的IBS减少了25%，并且与社会经济地位无关。IBS聚集在家庭和潜在的遗传和社会学因素进行审查。诊断为IBS的患者极有可能患有其他功能性疾病，并且比一般人群进行更多的手术。没有证据表明IBS与死亡风险增加有关。围绕这些方面的自然史的流行病学证据进行了讨论。
Irritable bowel syndrome (IBS) is a functional condition of the bowel that is diagnosed using clinical criteria. This paper discusses the nature of the diagnostic process for IBS and how this impacts epidemiological measurements. Depending on the diagnostic criteria employed, IBS affects around 11% of the population globally. Around 30% of people who experience the symptoms of IBS will consult physicians for their IBS symptoms. These people do not have significantly different abdominal symptoms to those who do not consult, but they do have greater levels of anxiety and lower quality of life. Internationally, there is a female predominance in the prevalence of IBS. There is 25% less IBS diagnosed in those over 50 years and there is no association with socioeconomic status. IBS aggregates within families and the genetic and sociological factors potentially underlying this are reviewed. Patients diagnosed with IBS are highly likely to have other functional disease and have more surgery than the general population. There is no evidence that IBS is associated with an increased mortality risk. The epidemiological evidence surrounding these aspects of the natural history is discussed.